Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas.

Kuranari, Yuki; Tamura, Ryota; Tsuda, Noboru; Kosugi, Kenzo; Morimoto, Yukina; Yoshida, Kazunari; Toda, Masahiro

Kuranari, Yuki; Tamura, Ryota; Tsuda, Noboru; Kosugi, Kenzo; Morimoto, Yukina; Yoshida, Kazunari; Toda, Masahiro.

Afiliação

Kuranari Y; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
Tamura R; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
Tsuda N; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Kosugi K; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
Morimoto Y; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
Yoshida K; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.
Toda M; Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan.

Front Oncol ; 10: 592470, 2020.

Article em En | MEDLINE | ID: mdl-33330078

Palavras-chave

World Health Organization grade I; meningioma; neutrophil-to-lymphocyte ratio; progression-free survival; recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google